Trade NXTC stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
NextCure, Inc. (NXTC) is trading at US$7.00, down 4.24% today as of Sep 11, 16:00 EDT. The company has a market capitalisation of US$28.79M. Over the past 52 weeks, NXTC has traded between US$1.55 and US$15.74. On Syfe you can trade NXTC with $0 commission and add it to your watchlist.
| Previous close | US$7.31 |
|---|---|
| Market cap | US$28.79M |
| 52-week range | US$1.55 – US$15.74 |
| Volume | 115.26K |
| Exchange | US |
Add to Watchlist
Set Price Alert
NextCure, Inc.
NextCure, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering and developing immunomedicines to treat cancer and other immune-related diseases. Its novel FIND-IO discovery technology identifies targets based on immunomodulatory function and on which the company is building a proprietary pipeline of immunomedicines. The company was founded by Michael S. Richman and Lie Ping Chen in September 2015 and is headquartered in Beltsville, MD.
Year: 2019
Sector Update: Healthcare Stocks Fall Late Afternoon
Jul 14, 7:46 PM · MT Newswires
Top Midday Gainers
Jul 14, 5:43 PM · MT Newswires
Sector Update: Healthcare Stocks Fall Tuesday Afternoon
Jul 14, 5:40 PM · MT Newswires
Sector Update: Healthcare Stocks Mixed Premarket Tuesday
Jul 14, 1:15 PM · MT Newswires
Top Premarket Gainers
Jul 14, 11:09 AM · MT Newswires
NextCure, Inc. (NXTC) stock is trading at US$7.00, -4.24% from the previous close of US$7.31.
The market cap for NextCure, Inc. (NXTC) stock is approximately US$28.79M.
The 52-week high for NextCure, Inc. (NXTC) stock is US$15.74.
The 52-week low for NextCure, Inc. (NXTC) stock is US$1.55.
NextCure, Inc. (NXTC) does not currently pay a dividend.
Stay on top of NXTC
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
